Canada End Stage Renal Disease Market Size & Outlook
- MedTech
- Nephrology Devices
- End Stage Renal Disease Market Outlook
- Nephrology Devices
Canada End Stage Renal Disease Market, 2018-2030 (US$M)
Global Market
Related Markets
Ask a question about the end stage renal disease market
Canada end stage renal disease market highlights
- The Canada end stage renal disease market generated a revenue of USD 1,844.2 million in 2023 and is expected to reach USD 4,072.1 million by 2030.
- The Canada market is expected to grow at a CAGR of 12% from 2024 to 2030.
- In terms of segment, dialysis was the largest revenue generating treatment type in 2023.
- Dialysis is the most lucrative treatment type segment registering the fastest growth during the forecast period.
End stage renal disease market data book summary
| Market revenue in 2023 | USD 1,844.2 million |
| Market revenue in 2030 | USD 4,072.1 million |
| Growth rate | 12% (CAGR from 2023 to 2030) |
| Largest segment | Dialysis |
| Fastest growing segment | Dialysis |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Transplant, Dialysis |
| Key market players worldwide | Nipro Corp, Fresenius SE & Co KGaA, Baxter International Inc, Medtronic PLC, B. Braun, BD, Asahi Kasei Corp, Cantel Medical, Nikkiso Co Ltd, JMS Support Japan |
Other key industry trends
- In terms of revenue, Canada accounted for 1.7% of the global end stage renal disease market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. end stage renal disease market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 37,790.2 million by 2030.
According to the Canadian Institute for Health Information’s (CIHI) report Canadian Organ Replacement Register (CORR), 2019, Manitoba, a Canadian Province, the number of people in Manitoba on dialysis has increased by 57% from 2009 to 2019.
In Canada, CKD, kidney transplant failure, and renal failure all qualify for the disability benefits from the Social Security Administration (SSA). Thus, increasing kidney transplantation, dialysis, rising prevalence of CKD, and increasing government initiatives are few factors driving the market.
No credit card required*
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
End Stage Renal Disease Market Scope
End Stage Renal Disease Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Baxter International Inc | View profile | 60,000 | One Baxter Parkway, Deerfield, IL, United States, 60015 | www.baxter.com |
| Medtronic PLC | View profile | 95,000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | www.medtronic.com |
| Fresenius SE & Co KGaA | View profile | 193,865 | Else-Kroener-Strasse 1, Bad Homburg, HE, Germany, 61352 | www.fresenius.com |
| Asahi Kasei Corp | View profile | 48,897 | 1-105 Kanda Jinbocho, Chiyoda-ku, Tokyo, Japan, 101-8101 | www.asahi-kasei.co.jp |
| B. Braun | View profile | 10001+ | Chapeltown, Sheffield, United Kingdom, Europe | www.bbraun.co.uk |
| Nipro Corp | View profile | 39,713 | 3-9-3 Honjo-Nishi Kita-ku, Osaka, Japan, 531-8510 | www.nipro.co.jp |
| Nikkiso Co Ltd | View profile | 8,529 | 4-20-3, Ebisu, Shibuya-ku, Tokyo, Japan, 150-6022 | www.nikkiso.co.jp |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | www.bd.com |
| Cantel Medical | View profile | 1001-5000 | Little Falls, New Jersey, United States, North America | www.cantelmedical.com |
| JMS Support Japan | View profile | 11-50 | Tokyo, Tokyo, Japan, Asia | jms-support.jp |
Canada End Stage Renal Disease Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to End Stage Renal Disease Market Outlook will help companies and investors design strategic landscapes.
Dialysis was the largest segment with a revenue share of 78.13% in 2023.
Horizon Databook has segmented the Canada end stage renal disease market based on transplant, dialysis covering the revenue growth of each sub-segment from 2018 to 2030.
According to the Canadian Institute for Health Information’s (CIHI) report Canadian Organ Replacement Register (CORR), 2019, Manitoba, a Canadian Province, the number of people in Manitoba on dialysis has increased by 57% from 2009 to 2019.
In Canada, CKD, kidney transplant failure, and renal failure all qualify for the disability benefits from the Social Security Administration (SSA). Thus, increasing kidney transplantation, dialysis, rising prevalence of CKD, and increasing government initiatives are few factors driving the market.
- Canada End Stage Renal Disease Market Treatment Type Outlook (Revenue, USD Million , 2018-2030)
- Transplant
- Dialysis
Reasons to subscribe to End Stage Renal Disease Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of End Stage Renal Disease Market Outlook databook
- Our clientele includes a mix of End Stage Renal Disease Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada End Stage Renal Disease Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Canada End Stage Renal Disease Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Canada End Stage Renal Disease Market, 2018-2030 (US$M)
Canada end stage renal disease market statistics, by treatment type, 2018-2030 (US$M)
